Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037116 (
silicosis
)
1,822
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dysregulation of apoptosis, particularly in the Fas/Fas ligand (FasL) pathway, is considered to be involved in the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE). Recently, a soluble decoy receptor, termed
decoy receptor 3
(
DcR3
), that binds FasL and inhibits FasL-induced apoptosis, has been identified.
Silicosis
is clinically characterized not only by respiratory disorders but by immunological abnormalities. We have found that serum soluble Fas (sFas) levels are elevated in
silicosis
patients and that sFas message is dominantly expressed in PBMC derived from these patients. This study examined
DcR3
gene expression in PBMC derived from patients with
silicosis
, SLE, or progressive systemic sclerosis (PSS), and compared it with that in healthy volunteers (HV). The relative expression level of the
DcR3
gene was examined in PBMC derived from 37 patients with
silicosis
without clinical symptoms of autoimmune disease, nine patients with SLE, 12 patients with PSS, and 28 HV using the semiquantitative multiplex-reverse transcriptase-polymerase chain reaction (MP-RT-PCR). The correlation between the relative expression level of the
DcR3
gene and multiple clinical parameters for respiratory disorders and immunological abnormalities in individuals with
silicosis
was analysed. The
DcR3
gene was significantly over-expressed in cases of
silicosis
or SLE when compared with HV. In addition, the
DcR3
relative expression level was positively correlated with the serum sFas level in
silicosis
patients. It is unclear, however, whether over-expression of the
DcR3
gene in
silicosis
is caused by chronic silica exposure, merely accompanies the alteration in Fas-related molecules, or precedes the clinical onset of autoimmune abnormalities. It will be necessary to study these patients further, establish an in vitro model of human T cells exposed recurrently to silica compounds, and resolve whether the increase in
DcR3
mRNA expression is a cause or consequence of disease.
...
PMID:Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. 1063 70